We are live on ! Find out more
AC

AlphaCore Capital Portfolio holdings

AUM $4.22B
1-Year Est. Return 21.28%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+21.28%
3 Year Est. Return
+68.34%
5 Year Est. Return
+65.67%
10 Year Est. Return
AUM
$4.22B
AUM Growth
-$265M
Cap. Flow
-$258M
Cap. Flow %
-6.12%
Top 10 Hldgs %
23.34%
Holding
1,540
New
118
Increased
332
Reduced
581
Closed
339

Sector Composition

1 Technology 6.67%
2 Energy 4.51%
3 Communication Services 3.81%
4 Financials 3.41%
5 Healthcare 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXUS icon
126
Vanguard Total International Stock ETF
VXUS
$153B
$6.25M 0.15%
81,013
+444
+0.6% +$35.3K
RSG icon
127
Republic Services
RSG
$68B
$5.99M 0.14%
27,341
+1,020
+4% +$224K
AVUS icon
128
Avantis US Equity ETF
AVUS
$13.8B
$5.96M 0.14%
53,644
-206
-0.4% -$23.6K
IWF icon
129
iShares Russell 1000 Growth ETF
IWF
$124B
$5.96M 0.14%
55,932
-2,428
-4% -$276K
VFH icon
130
Vanguard Financials ETF
VFH
$13.4B
$5.96M 0.14%
49,322
-18,412
-27% -$2.35M
AMGN icon
131
Amgen
AMGN
$196B
$5.93M 0.14%
16,842
+2,203
+15% +$785K
MRK icon
132
Merck
MRK
$315B
$5.92M 0.14%
48,866
-6,488
-12% -$749K
ITOT icon
133
iShares Core S&P Total US Stock Market ETF
ITOT
$94.1B
$5.92M 0.14%
41,529
+4,171
+11% +$620K
ORCL icon
134
Oracle
ORCL
$368B
$5.82M 0.14%
39,578
-1,501
-4% -$244K
IBM icon
135
IBM
IBM
$201B
$5.76M 0.14%
23,745
-2,080
-8% -$563K
CGXU icon
136
Capital Group International Focus Equity ETF
CGXU
$6.1B
$5.74M 0.14%
194,473
-13,427
-6% -$414K
C icon
137
Citigroup
C
$218B
$5.73M 0.14%
50,554
-7,004
-12% -$798K
AVES icon
138
Avantis Emerging Markets Value ETF
AVES
$1.44B
$5.71M 0.14%
95,226
-4,060
-4% -$252K
PXF icon
139
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
$5.68M 0.13%
81,285
-17,125
-17% -$1.21M
ETN icon
140
Eaton
ETN
$157B
$5.68M 0.13%
15,878
-1,611
-9% -$573K
IEF icon
141
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$5.67M 0.13%
59,414
-5,229
-8% -$503K
MGNR icon
142
American Beacon GLG Natural Resources ETF
MGNR
$836M
$5.59M 0.13%
+108,404
New +$5.45M
VUG icon
143
Vanguard Growth ETF
VUG
$222B
$5.54M 0.13%
76,146
-211,362
-74% -$16.4M
JHMM icon
144
John Hancock Multifactor Mid Cap ETF
JHMM
$5.87B
$5.51M 0.13%
82,150
-1,030
-1% -$70.8K
T icon
145
AT&T
T
$151B
$5.51M 0.13%
190,145
-28,412
-13% -$759K
TLH icon
146
iShares 10-20 Year Treasury Bond ETF
TLH
$11.1B
$5.43M 0.13%
53,867
-4,478
-8% -$457K
CB icon
147
Chubb
CB
$136B
$5.39M 0.13%
16,493
-1,228
-7% -$394K
LLY icon
148
Eli Lilly
LLY
$1.05T
$5.37M 0.13%
5,840
-1,443
-20% -$1.46M
RTX icon
149
RTX Corp
RTX
$262B
$5.35M 0.13%
27,725
+150
+0.5% +$29.8K
USMV icon
150
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$5.33M 0.13%
57,470
-1,017
-2% -$96.6K

Similar funds

AlphaCore Capital's Q1 2026 Portfolio in Review

As of Q1 2026, AlphaCore Capital held 1,540 positions worth $4.22B, down 5.9% from $4.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

AlphaCore Capital withdrew a net $258M in Q1 2026, closing 339 positions and reducing 581 holdings. Its most notable exit was Cidara Therapeutics, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, down from 7.5% a quarter earlier, followed by Energy and Communication Services.

Against the trend, AlphaCore Capital opened a new position in American Beacon GLG Natural Resources ETF worth $5.59M.

  • AlphaCore Capital's largest Q1 2026 buy was American Beacon GLG Natural Resources ETF: 108,404 shares worth $5.59M.
  • AlphaCore Capital added most to Vanguard Large-Cap ETF in Q1 2026, an estimated $51.1M increase.
  • AlphaCore Capital's biggest Q1 2026 reduction was ImmunityBio, cutting an estimated $20.4M.
  • AlphaCore Capital fully exited Cidara Therapeutics in Q1 2026, selling an estimated $14.8M.
  • AlphaCore Capital's ten largest holdings make up 23% of its $4.22B portfolio in Q1 2026.
  • AlphaCore Capital opened 118 new positions and closed 339 in Q1 2026.
  • AlphaCore Capital's portfolio value fell 5.9% quarter-over-quarter to $4.22B.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.